Amorphex Therapeutics
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1 Dundee Park Dr Ste 8, Andover, Massach...Phone Number
(978) 475-4491Website
www.amorphexusa.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Amorphex Therapeutics
Amorphex Therapeutics is focused on developing TODDD, a patented device designed to enhance ocular drug delivery for treating various ophthalmic diseases, including glaucoma. This innovative, soft device allows for continuous drug delivery to the eye, replacing traditional eye drop therapies that often lead to adherence issues and inadequate dosing. By providing a safe, non-invasive solution, TODDD aims to improve patient experiences and outcomes while minimizing side effects. The technology also opens avenues for treating conditions where conventional drops are ineffective, such as retinal diseases and myopia progression.Explore more
Popular SearchesAmorphex Therapeutics LLCAmorphexAmorphex Medical LLPAmore IncAmorphex Therapeutics Holdings IncSIC Code 38,384NAICS Code 33,339Show more
Amorphex Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Amorphex Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Amorphex Therapeutics
Product Launch: Get notified when Amorphex Therapeutics launches new products
Earning: See what the market has to say on Amorphex Therapeutics recently announced quarterly report
Click to see if Amorphex Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Amorphex Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Amorphex Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Amorphex Therapeutics has new funding data
Check out if Amorphex Therapeutics is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Amorphex Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Amorphex Therapeutics
Compare insights from companies similar to Amorphex Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Amorphex Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Amorphex Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Amorphex Therapeutics.
Amorphex Therapeutics Tech Stack
A closer look at the technologies used by Amorphex Therapeutics
See more technologies
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Amorphex Therapeutics
Sign Up For FreeTo access detailed company insights
Amorphex Therapeutics is focused on developing TODDD, a patented device designed to enhance ocular drug delivery for treating various ophthalmic diseases, including glaucoma. This innovative, soft device allows for continuous drug delivery to the eye, replacing traditional eye drop therapies that often lead to adherence issues and inadequate dosing... Read More
